T1	HMM 11 51	efficacy of mitomycin C plus doxorubicin
T2	HMM 881 895	response rates
T3	HMM 1121 1140	total response rate
T4	HMM 1216 1236	disease progression.
T5	HMM 1241 1258	progression rates
T6	HMM 1467 1482	efficacy to BCG
